Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 1760Sesión 2026

Qué cambió entre versiones

1178 párrafos cambiaron+1731 palabras agregadas−2759 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

Florida Senate

-

2026

CS for CS for SB 1760

By

the CommitteeCommittees on Appropriations; and Health Policy; and Senators Brodeur, Gaetz,

Rouson, and Massullo

Senators Brodeur, Gaetz, Rouson, Massullo, Garcia, and Harrell

588-02792-26576-03338-26 20261760c120261760c2

1 A bill to be entitled

12 párrafos sin cambios

2 An act relating to health care coverage; amending s.

3 1.01, F.S.; defining the term “Joint Legislative

4 Committee on Medicaid Oversight”; creating s. 11.405,

5 F.S.; establishing the Joint Legislative Committee on

6 Medicaid Oversight for specified purposes; providing

7 for membership, subcommittees, and meetings of the

8 committee; specifying duties of the committee;

9 authorizing the committee to submit periodic reports

10 to the Legislature; requiring the Auditor General and

11 the Agency for Health Care Administration to enter

12 into and maintain a data sharing agreement for a

13 certain purpose by a specified date; requiring the

14 Auditor General to assist the committee by providing

15 certain staff or consulting services; requiring thatstate

16 state agencies, political subdivisions of the state, and

17 and entities contracted with state agencies to give the

18 committee access to certain records, papers, and

11 párrafos sin cambios

19 documents; authorizing the committee to compel

20 testimony and evidence according to specified

21 provisions; providing for additional powers of the

22 committee; providing that certain joint rules of the

23 Legislature apply to the proceedings of the committee;

24 requiring the agency to notify the committee of

25 certain changes and provide a report containing

26 specified information to the committee; requiring the

27 agency to submit a copy of certain reports to the

28 committee; amending s. 409.962, F.S.; defining terms;

29 amending s. 409.967, F.S.; revising encounter data

30 reporting requirements for prepaid Medicaid plans;

31 requiring that the agency’s analysis of such encounter data

32 todata include identification of specified occurrences;

33 requiring the agency to use such analysis in setting

34 párrafos sin cambios

34 managed care plan capitation rates; requiring that

35 managed care plan contracts require any third-party

36 administrative entity contracted with the plan to

37 adhere to specified requirements; specifying

38 additional types of payments which may not be included

39 in calculating income for purposes of the achieved

40 savings rebate; requiring, rather than authorizing,

41 the agency to calculate the medical loss ratio for all

42 managed care plans under certain circumstances;

43 revising requirements for the calculation of medical

44 loss ratios; requiring the agency to report medical

45 loss ratios quarterly and annually for each managed

46 care plan to the Governor and the Legislature within a

47 specified timeframe; requiring the agency to ensure

48 oversight of affiliated entities and related parties

49 paid by managed care plans; requiring the agency to

50 examine specified records and data related to such

51 entities and parties; requiring the agency to consider

52 certain data and findings when developing managed care

53 plan capitation rates; revising the income sharing

54 ratios used to calculate the achieved savings rebate

55 beginning on a specified date; creating s. 409.9675,

56 F.S.; requiring managed care plans to report to the

57 agency and the Office of Insurance Regulation the

58 existence of and specified details relating to certain

59 affiliations by a specified date and annually

60 thereafter; requiring managed care plans to report any

61 change in such information to the agency and the

62 office in writing within a specified timeframe;

63 requiring the agency to calculate, analyze, and

64 publicly report on the agency’s website an assessment

65 of affiliated entity payment transactions in the

66 Medicaid program and certain administrative costs by a

67 specified date and annually thereafter; providing

68 requirements for the assessment; amending s. 626.8825,

69 F.S.; defining the termsterm “affiliated manufacturer” and;

70 “covered prescription drug”; revising the definition of the term “pharmacy benefits

71 plan or program”; revising requirements for contracts

72 between a pharmacy benefit manager and a participating

73 pharmacy; revising the frequency of and deadlines for

74 certain reports pharmacy benefit managers are required

75 to submit to the office beginning on a specified date;

76 amending s. 626.8827, F.S.; revising and specifying

7177 ofadditional thepractices term “pharmacy benefitsbenefit planmanagers or program”;are

72 revising requirements for contracts between a pharmacy

73 benefit manager and a pharmacy benefits plan or

78 prohibited from engaging in; amending s. 627.42392,

7479 programF.S.; andconforming a participating pharmacycross-reference; revising theproviding

75 frequency of and deadlines for certain reports

76 pharmacy benefit managers are required to submit to

7780 theeffective office beginning on a specified date; amending sdates.

78 626.8827, F.S.; revising and specifying additional

79 practices pharmacy benefit managers are prohibited

80 from engaging in; amending s. 627.42392, F.S.;

81 conforming a cross-reference; providing effective

82 dates.

81

82 Be It Enacted by the Legislature of the State of Florida:

83

84 Be It Enacted by the Legislature of the State of Florida:

85

8684 Section 1. Effective upon this act becoming a law,

8785 subsection (20) is added to section 1.01, Florida Statutes, to

8886 read:

8987 1.01 Definitions.—In construing these statutes and each and

9088 every word, phrase, or part hereof, where the context will

9189 permit:

9290

(20)

The term “Joint Legislative Committee on Medicaid

91

Oversight” means a committee or committees designated by joint

92

rule of the Legislature, by the President of the Senate or the

93

Oversight” means a committee or committees designated by joint

Speaker of the House of Representatives, or by agreement between

94

rule of the Legislature, by the President of the Senate orand the Speaker of the House of

95

Speaker of the House of Representatives, or by agreement between

96

the President of the Senate and the Speaker of the House of

97

Representatives.

9896 Section 2. Effective upon this act becoming a law, section

9997 11.405, Florida Statutes, is created to read:

100

98

11.405

J

oint Legislative Committee on Medicaid

Oversight.

101

99

The

Joint Legislative Committee on Medicaid

Oversight is created

100

to ensure that the state Medicaid program is operating in

101

accordance with the Legislature’s intent and to promote

102

to ensure that the state Medicaid program is operating in

transparency and efficiency in government spending.

103

accordance with the Legislature’s intent and to promote

104

transparency and efficiency in government spending.

105

(1)

3 párrafos sin cambios

MEMBERSHIP;

SUBCOMMITTEES

;

MEETINGS.—

106104

(a)

The committee shall be composed of five

members of the

107105

Senate appointed by the President of the Senate

and five

members

108106

of the House of Representatives appointed by the Speaker of the

109107

House of Representatives

, with each member serving a 2-year

110108

term

. The chair and vice chair shall

each

be appointed for 1

111

109

year terms

,

with the appointments alternating between

the

112110

President of the Senate

and

the Speaker of the House of

113111

Representatives. The chair and vice chair may not be members of

114112

the same house of the Legislature.

If both the chair and vice

113

chair are absent

from

any meeting, the members present

must

114

elect a temporary chair by a majority vote.

115

chair are absent at any meeting, the members present

must

elect

116

a temporary chair by a majority vote.

117

(

b

)

Members shall serve without compensation but may be

116

reimbursed for per diem and travel expenses pursuant to s.

117

112.061.

118

reimbursed for per diem and travel expenses pursuant to s.

119

112.061.

120

(

4 párrafos sin cambios

c

)

The chair may establish subcommittees

as needed

to

121119

fulfill

the committee’s

duties

.

122120

(

5 párrafos sin cambios

d

)

The committee shall convene at

least

twice a year,

and

123121

as often as necessary

3 párrafos sin cambios

to conduct

its

business as required

under

124122

this section

4 párrafos sin cambios

.

M

eetings may be held

through

teleconference or

125123

other electronic means.

126124

(2)

COMMITTEE DUTIES.—

127125

(a)

3 párrafos sin cambios

The

c

ommittee shall evaluate all aspects of the

state

128126

Medicaid program related to program financing, quality

of care

129127

and

health

outcomes, administrative functions, and operational

130

128

functions to ensure

4 párrafos sin cambios

that

the program

is provid

ing

transparency

131

129

in the

4 párrafos sin cambios

provision

of health care plans and providers,

en

sur

ing

132130

Medicaid recipients have

3 párrafos sin cambios

access to quality

health care

service

s

133131

and

5 párrafos sin cambios

providing

stability to

the state

’s budget

through

a health

134132

care delivery system designed to contain cost

s

.

135133

(

b

)

The committee shall identify and recommend policies

136134

that limit Medicaid spend

ing

growth while improving health care

137135

outcomes for

Medicaid

recipients.

In developing its

138136

recommendations, t

he committee shall

do all of the following

:

139137

1.

Evaluate legislation for its long-term impact on

the

140

138

state

Medicaid

program.

141

139

2.

Review data submitted

to the Agency for Health Care

142140

Administration

by the

Medicaid

managed care plans pursuant to

143141

statutory and contract requirements

3 párrafos sin cambios

,

including

,

but not limited

144142

to

,

timeliness of provider credentialing, timely payment of

145143

claims, rate of claim denial

s

, prior authorizations

for

146144

services,

and consumer complaints.

147145

3.

4 párrafos sin cambios

Review

the Medicaid

managed care plan

s’

encounter data,

148146

financial

4 párrafos sin cambios

data,

and audits

and the

data used to calculat

e the

149147

plans’

3 párrafos sin cambios

achieved savings rebate

s

and medical loss ratio

s.

150

148

4.

3 párrafos sin cambios

Review data related to

health

outcomes

of Medicaid

151

149

recipients,

5 párrafos sin cambios

including

,

but not limited to

,

Health

care

152150

Effectiveness Data and Information Set measure

s developed by the

153151

National Committee for Quality Assurance

, for each Medicaid

154152

managed care plan,

each

Medicaid managed care

plan’s performance

155153

improvement projects

,

and outcome data related to all quality

156154

goals included in the Medicaid managed care organization

157155

contracts

to

improve quality for

recipients.

158156

5.

Identify

any areas for

improvement in statu

t

ethe laws and rulerules

159157

relat

4 párrafos sin cambios

ing

to the

state

Medicaid program

.

160

158

6.

Develop a plan of action for the future of the

state

161

159

Medicaid program.

162160

(

4 párrafos sin cambios

c

)

The committee may

submit

periodic reports, including

163161

recommendations, to the Legislature on issues related to

the

164162

state Medicaid program and any affiliated

programs.

165163

(3)

COOPERATION.—

166164

(a)

The Auditor General and the Agency for Health Care

167165

Administration shall enter into and maintain a data

sharing

168166

agreement by July 1, 202

5 párrafos sin cambios

6,

to ensure the

c

ommittee ha

s

full

169167

access to all data needed to fulfill

its

responsibilities.

170

168

(b)

The Auditor General shall assist the

c

ommittee in its

171

169

work by providing credentialed professional staff or consulting

172170

services

, including, but not limited to,

an actuary not

173171

associated with

3 párrafos sin cambios

the state

Medicaid

p

rogram or any Medicaid

172

managed care organization who currently has a contract with the

173

state.

174

managed care organization who currently has a contract with the

175

state.

176

(c)

6 párrafos sin cambios

The

c

ommittee

, in the course

of

its

official duties,

177175

must be given

4 párrafos sin cambios

access to any

relevant record,

paper

,

or document

176

in possession of a state agency, any political subdivision of

177

the state, or any entity engaged in business or under contract

178

in possession of a state agency, any political subdivision of

179

the state, or any entity engaged in business or under contract

180

with a state agency,

and may compel the attendance

and testimony

181

179

of any

3 párrafos sin cambios

s

tate official or employee before the

c

ommittee or secure

182180

any evidence

as provided in s. 11.143. The committee may also

183181

have any other powers conferred on it by

joint rules of the

182

Senate and the House of Representatives, and any joint rules of

183

the Senate and the House of Representatives applicable to joint

184

Senate and the House of Representatives, and any joint rules of

185

the Senate and the House of Representatives applicable to joint

186

legislative committees

apply to the proceedings of the

c

ommittee

187185

under this section

.

188186

(4)

AGENCY REPORTS.—

189187

(a)

Before

implementing any change to the Medicaid managed

190

188

care capitation rates, the

Agency for Health Care Administration

191189

shall notify

the committee of the change

and appear before the

192190

c

ommittee

to

provide a report detailing the managed care

193191

capitation rates and administrative costs built into the

194192

capitation rates. The report

3 párrafos sin cambios

must

include the

agency

’s

193

historical and projected Medicaid program expenditure and

194

utilization trend rates by Medicaid program and service category

195

historical and projected Medicaid program expenditure and

for the rate year, an explanation of

the manner in which

the

196

utilization trend rates by Medicaid program and service category

trend rates were calculated

,

and the policy decisions that were

197

for the rate year, an explanation of how the trend rates were

198

calculatedincluded in

,

and the policy decisions that were included in

199

setting

the capitation rates.

200

198

(b)

3 párrafos sin cambios

If

the

Agency for Health Care Administration

or any

201

199

division within the

a

gency is required by law to report to the

202200

Legislature or to any

legislative

committee or subcommittee on

203201

matters relating to the

4 párrafos sin cambios

state

Medicaid program, the

a

gency

must

204202

also

3 párrafos sin cambios

submit

a copy of the report to the

c

ommittee.

205203 Section 3. Present subsections (2) through (5), (6) through

206204 (10), and (11) through (18) of section 409.962, Florida

207205 Statutes, are redesignated as subsections (3) through (6), (8)

208206 through (12), and (14) through (21), respectively, and new

209207 subsections (2), (7), and (13) are added to that section, to

210208 read:

211209 409.962 Definitions.—As used in this part, except as

212210 otherwise specifically provided, the term:

213211

(2) “Affiliate

,

” including the terms “affiliated with” and

214212

“affiliation

4 párrafos sin cambios

,

” means a person

, as construed in s. 1.01(3),

who

:

215213

(a)

3 párrafos sin cambios

D

irectly or indirectly

,

through one or more

216214

intermediaries

,

controls, is controlled by, or is under common

217215

control with a specified entity or person

, including

parent

and

218216

subsidiary

entities; or

219217

(b)

Is deemed a “related party” according to the standards

218

adopted by the Financial Accounting Standards Board.

219

(7) “Control,” including the terms “controlling,”

220

adopted by the Financial Accounting Standards Board.

“controlled by,” and “under common control with,” means the

221

(7) “Control,” including the terms “controlling,”

possession, direct or indirect, of the power to direct or cause

222

“controlled by,” and “under common control with,” means the

the direction of the management and policies of a person,

223

possession, direct or indirect, of the power to direct or cause

whether through the ownership or voting securities, by contract

224

the direction of the management and policies of a person,

other than a commercial contract for goods or nonmanagement

225

whether through the ownership or voting securities, by contract

services, or otherwise, unless the power is the result of an

226

other than a commercial contract for goods or nonmanagement

official position with or corporate office held by the person.

227

services, or otherwise, unless the power is the result of an

228

official position with or corporate office held by the person.

229

This definition applies

regardless of whether such power is

230

228

affirmative or negative

or

whether such power is actually used

.

231

229

Control

is

presumed to exist, but is not limited to, when any

232230

affiliate

3 párrafos sin cambios

or

person

, as construed in s. 1.01(3)

:

233231

(a)

Directly or indirectly owns, controls, holds the power

232

to vote, or holds proxies representing 10 percent or more of any

233

class of the voting securities of any other person.

234

to vote, or holds proxies representing 10 percent or more of any

235

class of the voting securities of any other person.

236

(b)

Shares common ownership with any person

;

has an

237235

investor or is a holder of an ownership interest

in

any person

;

236

exercises control in any manner over the election of a majority

237

of the directors or of individuals exercising similar functions

238

exercises control in any manner over the election of a majority

239

of the directors or of individuals exercising similar functions

240

of any person

;

has the power to exercise controlling influence

241

239

over the management of any person

;

or serves as a working

242240

majority of the board of directors,

the

managers, or the

243241

officers of a person, who is:

244242

1.

A provider

or a member of a

provider group or group

245243

practice

3 párrafos sin cambios

as

defined in s. 456.053

(3) under

the managed care

246244

plan

;

or

247245

2.

A person responsible for providing any pharmacy

246

services, pharmaceuticals, diagnostics, care coordination, care

247

delivery, health care services, medical equipment,

248

services, pharmaceuticals, diagnostics, care coordination, care

249

delivery, health care services, medical equipment,

250

administrative services, or financial services

under

the managed

251

249

care plan.

252250

(13)

4 párrafos sin cambios

“

Market rate

”

means t

he price that a willing buyer

253251

will

4 párrafos sin cambios

pay and a willing seller

will

accept in an arm

’

s-length

254252

transaction

which

is beneficial to both parties.

255253 Section 4. Subsections (1) and (2), paragraph (h) of

256254 subsection (3), and subsection (4) of section 409.967, Florida

257255 Statutes, are amended, and subsection (5) is added to that

258256 section, to read:

259257 409.967 Managed care plan accountability.—

260258 (1)

CONTRACT PROCUREMENT PROCESS.—

Beginning with the

261259 contract procurement process initiated during the 2023 calendar

262260 year, the agency shall establish a 6-year contract with each

263261 managed care plan selected through the procurement process

264262 described in s. 409.966. A plan contract may not be renewed;

265263 however, the agency may extend the term of a plan contract to

266264 cover any delays during the transition to a new plan. The agency

267265 shall extend until December 31, 2024, the term of existing plan

268266 contracts awarded pursuant to the invitation to negotiate

269267 published in July 2017.

270268 (2)

CONTRACT REQUIREMENTS.—

The agency shall establish such

271269 contract requirements as are necessary for the operation of the

272270 statewide managed care program. In addition to any other

273271 provisions the agency may deem necessary, the contract must

274272 require:

275273 (a)

Physician compensation.

—Managed care plans are expected

276274 to coordinate care, manage chronic disease, and prevent the need

277275 for more costly services. Effective care management should

278276 enable plans to redirect available resources and increase

279277 compensation for physicians. Plans achieve this performance

280278 standard when physician payment rates equal or exceed Medicare

281279 rates for similar services. The agency may impose fines or other

282280 sanctions on a plan that fails to meet this performance standard

283281 after 2 years of continuous operation.

284282 (b)

Emergency services.

—Managed care plans shall pay for

285283 services required by ss. 395.1041 and 401.45 and rendered by a

286284 noncontracted provider. The plans must comply with s. 641.3155.

287285 Reimbursement for services under this paragraph is the lesser

288286 of:

289287 1. The provider’s charges;

290288 2. The usual and customary provider charges for similar

291289 services in the community where the services were provided;

292290 3. The charge mutually agreed to by the entity and the

293291 provider within 60 days after submittal of the claim; or

294292 4. The Medicaid rate, which, for the purposes of this

295293 paragraph, means the amount the provider would collect from the

296294 agency on a fee-for-service basis, less any amounts for the

297295 indirect costs of medical education and the direct costs of

298296 graduate medical education that are otherwise included in the

299297 agency’s fee-for-service payment, as required under 42 U.S.C. s.

300298 1396u-2(b)(2)(D). For the purpose of establishing the amounts

301299 specified in this subparagraph, the agency shall publish on its

302300 website annually, or more frequently as needed, the applicable

303301 fee-for-service fee schedules and their effective dates, less

304302 any amounts for indirect costs of medical education and direct

305303 costs of graduate medical education that are otherwise included

306304 in the agency’s fee-for-service payments.

307305 (c)

Access.

—

308306 1. The agency shall establish specific standards for the

309307 number, type, and regional distribution of providers in managed

310308 care plan networks to ensure access to care for both adults and

311309 children. Each plan must maintain a regionwide network of

312310 providers in sufficient numbers to meet the access standards for

313311 specific medical services for all recipients enrolled in the

314312 plan. The exclusive use of mail-order pharmacies may not be

315313 sufficient to meet network access standards. Consistent with the

316314 standards established by the agency, provider networks may

317315 include providers located outside the region. Each plan shall

318316 establish and maintain an accurate and complete electronic

319317 database of contracted providers, including information about

320318 licensure or registration, locations and hours of operation,

321319 specialty credentials and other certifications, specific

322320 performance indicators, and such other information as the agency

323321 deems necessary. The database must be available online to both

324322 the agency and the public and have the capability to compare the

325323 availability of providers to network adequacy standards and to

326324 accept and display feedback from each provider’s patients. Each

327325 plan shall submit quarterly reports to the agency identifying

328326 the number of enrollees assigned to each primary care provider.

329327 The agency shall conduct, or contract for, systematic and

330328 continuous testing of the provider network databases maintained

331329 by each plan to confirm accuracy, confirm that behavioral health

332330 providers are accepting enrollees, and confirm that enrollees

333331 have access to behavioral health services.

334332 2. Each managed care plan must publish any prescribed drug

335333 formulary or preferred drug list on the plan’s website in a

336334 manner that is accessible to and searchable by enrollees and

337335 providers. The plan must update the list within 24 hours after

338336 making a change. Each plan must ensure that the prior

339337 authorization process for prescribed drugs is readily accessible

340338 to health care providers, including posting appropriate contact

341339 information on its website and providing timely responses to

342340 providers. For Medicaid recipients diagnosed with hemophilia who

343341 have been prescribed anti-hemophilic-factor replacement

344342 products, the agency shall provide for those products and

345343 hemophilia overlay services through the agency’s hemophilia

346344 disease management program.

347345 3. Managed care plans, and their fiscal agents or

348346 intermediaries, must accept prior authorization requests for any

349347 service electronically.

350348 4. Managed care plans serving children in the care and

351349 custody of the Department of Children and Families must maintain

352350 complete medical, dental, and behavioral health encounter

353351 information and participate in making such information available

354352 to the department or the applicable contracted community-based

355353 care lead agency for use in providing comprehensive and

356354 coordinated case management. The agency and the department shall

357355 establish an interagency agreement to provide guidance for the

358356 format, confidentiality, recipient, scope, and method of

359357 information to be made available and the deadlines for

360358 submission of the data. The scope of information available to

361359 the department shall be the data that managed care plans are

362360 required to submit to the agency. The agency shall determine the

363361 plan’s compliance with standards for access to medical, dental,

364362 and behavioral health services; the use of medications; and

365363

follow-up

followup

on all medically necessary services

366364 recommended as a result of early and periodic screening,

367365 diagnosis, and treatment.

368366 (d)

Quality care.

—Managed care plans shall provide, or

369367 contract for the provision of, care coordination to facilitate

370368 the appropriate delivery of behavioral health care services in

371369 the least restrictive setting with treatment and recovery

372370 capabilities that address the needs of the patient. Services

373371 shall be provided in a manner that integrates behavioral health

374372 services and primary care. Plans shall be required to achieve

375373 specific behavioral health outcome standards, established by the

376374 agency in consultation with the department.

377375 (e)

Encounter data.

—The agency shall maintain and operate a

378376 Medicaid Encounter Data System to collect, process, store, and

379377 report on covered services provided to all Medicaid recipients

380378 enrolled in prepaid plans.

381379 1. Each prepaid plan must comply with the agency’s

382380 reporting requirements for the Medicaid Encounter Data System.

383381 Prepaid plans must submit encounter data

, including data on

382

encounters for which payment was denied and encounters for which

383

a health care provider was reimbursed by the plan on a capitated

384

encounters for which payment was denied and encounters for which

385

a health care provider was reimbursed by the plan on a capitated

386

basis,

electronically in a format that complies with the Health

387385 Insurance Portability and Accountability Act provisions for

388386 electronic claims and in accordance with deadlines established

389387 by the agency. Prepaid plans must certify that the data reported

390388 is accurate and complete.

391389 2. The agency is responsible for validating the data

392390 submitted by the plans. The agency shall develop methods and

393391 protocols for ongoing analysis of the encounter data that

394392 adjusts for differences in characteristics of prepaid plan

395393 enrollees to allow comparison of service utilization among plans

396394 and against expected levels of use. The analysis shall be used

397395 to identify possible cases of

overspending on administrative

398396

costs, payments by plans in excess of market rates,

systemic

399397 underutilization or denials of claims and inappropriate service

400398 utilization such as higher-than-expected emergency department

401399 encounters

, and potential

managed care plan

fraud, waste, and

402400

abuse

. The analysis shall provide periodic feedback to the plans

403401 and enable the agency to establish corrective action plans when

404402 necessary. One of the focus areas for the analysis shall be the

405403 use of prescription drugs.

The analysis shall be used in managed

406404

care plan

3 párrafos sin cambios

capitation

rate

-

setting processes provided under this

407405

part.

408406 3. The agency shall make encounter data available to those

409407 plans accepting enrollees who are assigned to them from other

410408 plans leaving a region.

411409 4. The agency shall annually produce a report entitled

412410 “Analysis of Potentially Preventable Health Care Events of

413411 Florida Medicaid Enrollees.” The report must include, but need

414412 not be limited to, an analysis of the potentially preventable

415413 hospital emergency department visits, hospital admissions, and

416414 hospital readmissions that occurred during the previous state

417415 fiscal year which may have been prevented with better access to

418416 primary care, improved medication management, or better

419417 coordination of care, reported by age, eligibility group,

420418 managed care plan, and region, including conditions contributing

421419 to each potentially preventable event or category of potentially

422420 preventable events. The agency may include any other data or

423421 analysis parameters to augment the report which it deems

424422 pertinent to the analysis. The report must demonstrate trends

425423 using applicable historical data. The agency shall submit the

426424 report to the Governor, the President of the Senate, and the

427425 Speaker of the House of Representatives by October 1, 2024, and

428426 each October 1 thereafter. The agency may contract with a third

429427 party vendor to produce the report required under this

430428 subparagraph.

431429 (f)

Continuous improvement.

—The agency shall establish

432430 specific performance standards and expected milestones or

433431 timelines for improving performance over the term of the

434432 contract.

435433 1. Each managed care plan shall establish an internal

436434 health care quality improvement system, including enrollee

437435 satisfaction and disenrollment surveys. The quality improvement

438436 system must include incentives and disincentives for network

439437 providers.

440438 2. Each managed care plan must collect and report the

441439 Healthcare Effectiveness Data and Information Set (HEDIS)

442440 measures, the federal Core Set of Children’s Health Care Quality

443441 measures, and the federal Core Set of Adult Health Care Quality

444442 Measures, as specified by the agency. Each plan must collect and

445443 report the Adult Core Set behavioral health measures beginning

446444 with data reports for the 2025 calendar year. Each plan must

447445 stratify reported measures by age, sex, race, ethnicity, primary

448446 language, and whether the enrollee received a Social Security

449447 Administration determination of disability for purposes of

450448 Supplemental Security Income beginning with data reports for the

451449 2026 calendar year. A plan’s performance on these measures must

452450 be published on the plan’s website in a manner that allows

453451 recipients to reliably compare the performance of plans. The

454452 agency shall use the measures as a tool to monitor plan

455453 performance.

456454 3. Each managed care plan must be accredited by the

457455 National Committee for Quality Assurance, the Joint Commission,

458456 or another nationally recognized accrediting body, or have

459457 initiated the accreditation process, within 1 year after the

460458 contract is executed. For any plan not accredited within 18

461459 months after executing the contract, the agency shall suspend

462460 automatic assignment under ss. 409.977 and 409.984.

463461 (g)

Program integrity.

—Each managed care plan shall

464462 establish program integrity functions and activities to reduce

465463 the incidence of fraud and abuse, including, at a minimum:

466464 1. A provider credentialing system and ongoing provider

467465 monitoring, including maintenance of written provider

468466 credentialing policies and procedures which comply with federal

469467 and agency guidelines;

470468 2. An effective prepayment and postpayment review process

471469 including, but not limited to, data analysis, system editing,

472470 and auditing of network providers;

473471 3. Procedures for reporting instances of fraud and abuse

474472 pursuant to chapter 641;

475473 4. Administrative and management arrangements or

476474 procedures, including a mandatory compliance plan, designed to

477475 prevent fraud and abuse; and

478476 5. Designation of a program integrity compliance officer.

479477 (h)

Grievance resolution.

—Consistent with federal law, each

480478 managed care plan shall establish and the agency shall approve

481479 an internal process for reviewing and responding to grievances

482480 from enrollees. Each plan shall submit quarterly reports on the

483481 number, description, and outcome of grievances filed by

484482 enrollees.

485483 (i)

Penalties.

—

486484 1. Withdrawal and enrollment reduction.—Managed care plans

487485 that reduce enrollment levels or leave a region before the end

488486 of the contract term must reimburse the agency for the cost of

489487 enrollment changes and other transition activities. If more than

490488 one plan leaves a region at the same time, costs must be shared

491489 by the departing plans proportionate to their enrollments. In

492490 addition to the payment of costs, departing provider services

493491 networks must pay a per-enrollee penalty of up to 3 months’

494492 payment and continue to provide services to the enrollee for 90

495493 days or until the enrollee is enrolled in another plan,

496494 whichever occurs first. In addition to payment of costs, all

497495 other departing plans must pay a penalty of 25 percent of that

498496 portion of the minimum surplus maintained pursuant to s.

499497 641.225(1) which is attributable to the provision of coverage to

500498 Medicaid enrollees. Plans shall provide at least 180 days’

501499 notice to the agency before withdrawing from a region. If a

502500 managed care plan leaves a region before the end of the contract

503501 term, the agency shall terminate all contracts with that plan in

504502 other regions pursuant to the termination procedures in

505503 subparagraph 3.

506504 2. Encounter data.—If a plan fails to comply with the

507505 encounter data reporting requirements of this section for 30

508506 days, the agency must assess a fine of $5,000 per day for each

509507 day of noncompliance beginning on the 31st day. On the 31st day,

510508 the agency must notify the plan that the agency will initiate

511509 contract termination procedures on the 90th day unless the plan

512510 comes into compliance before that date.

513511 3. Termination.—If the agency terminates more than one

514512 regional contract with the same managed care plan due to

515513 noncompliance with the requirements of this section, the agency

516514 shall terminate all the regional contracts held by that plan.

517515 When terminating multiple contracts, the agency must develop a

518516 plan to provide for the transition of enrollees to other plans,

519517 and phase in the terminations over a time period sufficient to

520518 ensure a smooth transition.

521519 (j)

Prompt payment.

—Managed care plans shall comply with

522520 ss. 641.315, 641.3155, and 641.513.

523521 (k)

Electronic claims.

—Managed care plans, and their fiscal

524522 agents or intermediaries, shall accept electronic claims in

525523 compliance with federal standards.

526524 (l)

Fair payment.

—Provider service networks must ensure

527525 that no entity licensed under chapter 395 with a controlling

528526 interest in the network charges a Medicaid managed care plan

529527 more than the amount paid to that provider by the provider

530528 service network for the same service.

531529 (m)

Itemized payment.

—Any claims payment to a provider by a

532530 managed care plan, or by a fiscal agent or intermediary of the

533531 plan, must be accompanied by an itemized accounting of the

534532 individual claims included in the payment including, but not

535533 limited to, the enrollee’s name, the date of service, the

536534 procedure code, the amount of reimbursement, and the

537535 identification of the plan on whose behalf the payment is made.

538536 (n)

Provider dispute resolution.

—Disputes between a plan

539537 and a provider may be resolved as described in s. 408.7057.

540538 (o)

Transparency.

—Managed care plans shall comply with ss.

541539 627.6385(3) and 641.54(7).

542540

(p)

Third-party administrators.—

The agency′s contract with

541

a managed care plan must require that any third-party

542

administrative entity contracted by the plan adheres to all

543

a managed care plan must require that any third-party

544

administrative entity contracted by the plan adheres to all

545

pertinent requirements

of the Medicaid program

placed on the

546544

plan

under

the plan′s contract with the agency.

547545 (3) ACHIEVED SAVINGS REBATE.—

548546 (h) The following may not be included as allowable expenses

549547 in calculating income for determining the achieved savings

550548 rebate:

551549 1. Payment of achieved savings rebates.

552550 2. Any financial incentive payments made to the plan

553551 outside of the capitation rate.

554552 3. Any financial disincentive payments levied by the state

555553 or Federal Government.

556554 4. Expenses associated with any lobbying or political

557555 activities.

558556 5. The cash value or equivalent cash value of bonuses of

559557 any type paid or awarded to the plan’s executive staff, other

560558 than base salary.

561559 6. Reserves and reserve accounts.

562560 7. Administrative costs, including, but not limited to,

563561 reinsurance expenses, interest payments, depreciation expenses,

564562 bad debt expenses, and outstanding claims expenses in excess of

565563 actuarially sound maximum amounts set by the agency.

566564

8. Payments to affiliate

s as defined in s. 409.962

in

567565

excess of market rates.

568566

569567 The agency shall consider these and other factors in developing

570568 contracts that establish shared savings arrangements.

571569 (4) MEDICAL LOSS

RATIOS

RATIO

.—

572570

(a)

If required

by federal regulations or

as a condition of

573571 a waiver, the agency

must

4 párrafos sin cambios

may

calculate

a

medical loss

ratios

574572

ratio

3 párrafos sin cambios

for

all

managed care plans

contracted with the agency

575573

under this part

4 párrafos sin cambios

. The

calculation

s must

calculation shall

use

576574 uniform financial data collected from all plans

and shall be

577575

computed for each plan on a statewide basis

.

If a plan

576

participates in the managed medical assistance program, the

577

long-term care managed care program, or the pilot program for

578

participates in the managed medical assistance program, the

individuals with developmental disabilities, the agency must

579

long-termcalculate caremedical managedloss careratios program, orfor the pilotplan’s programparticipation forin

580

individuals with developmental disabilities, the agency must

each program separately and, if the plan participates in more

581

calculatethan medicalone lossof ratiosthese programs, for the plan’s overall participation in

582

each program separately and, if the plan participates in more

583

than one of these programs, for the plan’s overall participation

584

in statewide

Medicaid

managed care.

Medical loss ratios must be

585583

calculated and

The method for calculating the medical loss ratio

586584

shall meet the following criteria:

587585

(a) Except as provided in paragraphs (b) and (c),

588586 expenditures

must

shall

be classified in a manner consistent

589587 with

42 C.F.R. part 438

45 C.F.R. part 158

.

590588 (b)

The agency shall report medical loss ratios quarterly

591589

and annually for each

managed care

plan

contracted with the

592590

agency under this part

to the Governor, the President of the

593591

Senate, and the Speaker of the House of Representatives no later

594592

than 6 months after the end of each

such

period

Funds provided

593

by plans to graduate medical education institutions to

594

underwrite the costs of residency positions shall be classified

595

by plans to graduate medical education institutions to

as medical expenditures, provided the funding is sufficient to

596

underwrite the costs of residency positions shall be classified

sustain the positions for the number of years necessary to

597

as medical expenditures, provided the funding is sufficient to

complete the residency requirements and the residency positions

598

sustain the positions for the number of years necessary to

funded by the plans are active providers of care to Medicaid and

599

complete the residency requirements and the residency positions

uninsured patients.

600

funded by the plans are active providers of care to Medicaid and

(c) Before final determination of the medical loss ratio

601

uninsured patients.

for any period, a plan may contribute to a designated state

602

(c) Before final determination of the medical loss ratio

trust fund for the purpose of supporting Medicaid and indigent

603

for any period, a plan may contribute to a designated state

care and have the contribution counted as a medical expenditure

604

trust fund for the purpose of supporting Medicaid and indigent

for the period. Funds contributed for this purpose shall be

605

care and have the contribution counted as a medical expenditure

606

for the period. Funds contributed for this purpose shall be

607

deposited into the Grants and Donations Trust Fund

.

606

(5) AFFILIATED ENTITIES AND RELATED PARTIES.—

607

(a) The agency shall ensure oversight of affiliated

608

(5) AFFILIATED ENTITIES AND RELATED PARTIES.—

entities and related parties paid by managed care plans under

609

(a) The agency shall ensure oversight of affiliated

this part, including, but not limited to, examining financial

610

entitiesrecords and relatedself-referral partiesdata paidof byany managed care plans underplan

611

this part, including, but not limited to, examining financial

612

records and self-referral data of any managed care plan

613

providing services within the

5 párrafos sin cambios

s

tatewide

m

anaged

c

are program

614612

which uses

affiliated entities and related parties.

615613

(b) The agency shall consider data examined under paragraph

616614

(a) and the findings of the annual

assessment

required under s.

617615

409.9675(4) when developing managed care plan capitation rates

618616

under this part.

619617 Section 5. Effective January 1, 2027, paragraph (f) of

620618 subsection (3) of section 409.967, Florida Statutes, is amended,

621619 and paragraph (g) of that subsection is republished, to read:

622620 409.967 Managed care plan accountability.—

623621 (3) ACHIEVED SAVINGS REBATE.—

624622 (f) Achieved savings rebates validated by the certified

625623 public accountant are due within 30 days after the report is

626624 submitted. Except as provided in paragraph (h), the achieved

627625 savings rebate is established by determining pretax income as a

628626 percentage of revenues and applying the following income sharing

629627 ratios:

630628 1. One hundred percent of income up to and including

3

5

631629 percent of revenue shall be retained by the plan.

632630 2.

Thirty

4 párrafos sin cambios

Fifty

percent of income above

3

5

percent and up

633631 to 10 percent shall be retained by the plan, and the other

70

50

634632 percent shall be refunded to the state and adjusted for the

635633 Federal Medical Assistance Percentages. The state share shall be

636634 transferred to the General Revenue Fund, unallocated, and the

637635 federal share shall be transferred to the Medical Care Trust

638636 Fund, unallocated.

639637 3. One hundred percent of income above 10 percent of

640638 revenue shall be refunded to the state and adjusted for the

641639 Federal Medical Assistance Percentages. The state share shall be

642640 transferred to the General Revenue Fund, unallocated, and the

643641 federal share shall be transferred to the Medical Care Trust

644642 Fund, unallocated.

645643 (g) A plan that exceeds agency-defined quality measures in

646644 the reporting period may retain an additional 1 percent of

647645 revenue. For the purpose of this paragraph, the quality measures

648646 must include plan performance for preventing or managing

649647 complex, chronic conditions that are associated with an elevated

650648 likelihood of requiring high-cost medical treatments.

651649 Section 6. Section 409.9675, Florida Statutes, is created

652650 to read:

653651

409.9675

Affiliated entities and controlling interests;

654652

reports required

.—

655653

(1) Each managed care plan contracted by the agency under

656654

this part shall report

all of

the following by March 31, 2027,

657655

for the prior calendar year,

and annually thereafter, to the

658656

agency and the Office of Insurance Regulation in

a

manner

659657

prescribed by the agency:

660

658

(a)

Any person controlled by or affiliated with the managed

661

659

care plan, including, but not limited to, any provider, provider

662660

group, group practice defined in s. 456.053

(3)

, or person

661

responsible for providing any pharmacy services,

662

pharmaceuticals, diagnostics, care coordination, care delivery,

663

responsible for providing any pharmacy services,

health care services, medical equipment, administrative

664

pharmaceuticals, diagnostics, care coordination, care delivery,

services, or financial services for, to, or on behalf of the

665

health care services, medical equipment, administrative

managed care plan.

666

services, or financial services for, to, or on behalf of the

667

managed care plan.

668

(b)

Any affiliation of any kind or nature with any person

667

wh

o

has, either directly or indirectly through one or more

668

intermediaries, an investment or ownership interest representing

669

which has, either directly or indirectly through one or more

10 percent or more, shares common ownership with, or has an

670

intermediaries,investor or a holder of an investment or ownership interest representing 10

671

10 percent or more, shares common ownership with, or has an

672

investor or a holder of an ownership interest representing 10

673

percent or more

with

any person providing pharmacy services,

672

diagnostics, care coordination, care delivery, health care

673

services, medical equipment, administrative services, or

674

diagnostics, care coordination, care delivery, health care

financial services for, to, or on behalf of the managed care

675

services, medical equipment, administrative services, or

plan.

676

financial services for, to, or on behalf of the managed care

677

plan.

678

(2)

For any affiliation reported by a

managed care plan

679677

under subsection (1)

, the report must include all of the

680678

following

:

679

(a) The percentage of ownership or control of any person or

680

affiliate with whom the managed care plan has had business

681

(a) The percentage of ownership or control of any person or

transactions totaling in the aggregate more than $25,000 during

682

affiliate with whom the managed care plan has had business

683

transactions totaling in the aggregate more than $25,000 during

684

the

prior

12-month period in the annual achieved savings rebate

685683

financial r

eport

ing required under s. 409.967(3)

and

686684

identif

ication of

the specific contract or contracts involved in

687685

such business transactions

.

686

(b) Any significant business transactions between the

687

managed care plan and any affiliated person during the 12-month

688

(b) Any significant business transactions between the

689

managed care plan and any affiliated person during the 12-month

690

period in the annual achieved savings rebate

financial r

eport

ing

691689

required under s. 409.967(3)

.

690

(3) Each managed care plan shall report any change in

691

information required by subsection (1) to the agency and the

692

(3) Each managed care plan shall report any change in

693

information required by subsection (1) to the agency and the

694

Office of Insurance Regulation in writing

within

60 days after

695693

the change occurs.

696694

(4)

By December 31, 2026, and annually thereafter, the

697695

agency shall calculate, analyze

,

and publicly report on the

698696

agency’s website an assessment of affiliated entity payment

699697

transactions in the Medicaid

p

rogram for medical benefit and

700

698

administrative costs as reported for purposes of the achieved

701

699

savings rebate. The baseline assessment, at a minimum,

must

702700

include

7 párrafos sin cambios

a

chieved

s

avings

r

ebate transactions

for the years

2021,

703701

2022, and 2023

;

the amount and associated percentage of

704702

affiliated entity payments within the medical loss ratio

;

and

705703

the payment deviation percentages and associated amounts at the

706704

Healthcare Common Procedure Cod

ing System

level for affiliated

707705

entities as compared to nonaffiliated entities.

The assessment

708706

must

also compare payment amounts for value-based or alternative

709707

payment arrangements

.

710708 Section 7. Present paragraphs (b), through (cx), andof (d), and (e)subsection

711709 through (x) of subsection (1) of section 626.8825, Florida Statutes, are redesignated as

710 paragraphs (c) through (z), respectively, a new paragraph (b) is

711 added to that subsection, and present paragraph (u) of

712 Statutes,subsection are(1) redesignated asand paragraphs (c), (d), and (eh), andof subsection (3) of

713 (g) through (z), respectively, new paragraphs (b) and (f) are

714 added to that subsection, and present paragraph (u) of

715 subsection (1), paragraphs (e) and (g) of subsection (2), and

716 paragraphs (c) and (h) of subsection (3) of that section are

717713 that section are amended, to read:

718714 626.8825 Pharmacy benefit manager transparency and

719715 accountability.—

720716 (1) DEFINITIONS.—As used in this section, the term:

721717

(

b

)

“Affiliated manufacturer” means a prescription drug

722

718

manufacturer permitted under

3 párrafos sin cambios

c

hapter 4

99 or

a private label

723

719

distributor as defined in 21 C.F.R. s. 207.1 which

directly or

720

indirectly through one or more intermediaries:

721

1. Has an investment or ownership interest in a pharmacy

722

benefit manager holding a certificate of authority issued under

723

this part;

724

indirectly through one or more intermediaries:

2. Shares common ownership with a pharmacy benefit manager

725

1. Has an investment or ownership interest in a pharmacy

holding a certificate of authority issued under this part; or

726

benefit manager holding a certificate of authority issued under

3. Has an investor or a holder of an ownership interest

727

this part;

which is a pharmacy benefit manager holding a certificate of

728

2. Shares common ownership with a pharmacy benefit manager

authority issued under this part.

729

holding a certificate of authority issued under this part; or

730

3. Has an investor or a holder of an ownership interest

731

which is a pharmacy benefit manager holding a certificate of

732

authority issued under this part.

733

(f) “Covered prescription drug” means any drug or biologic

734

included in a pharmacy benefit manager’s formulary which is paid

735

for as a pharmacy benefit under the plan at any of the plan’s

736

network pharmacies.

737

(

w

v

)

(u)

“Pharmacy benefits plan or program” means a plan or

738730 program that pays for, reimburses, covers the cost of, or

739731 provides access to discounts on pharmacist services provided by

740732 one or more pharmacies to covered persons who reside in, are

741733 employed by, or receive pharmacist services from this state.

742734 1. The term includes, but is not limited to, health

743735 maintenance organizations, health insurers, self-insured

744736 employer health plans, discount card programs, and government

745737 funded health plans, including the Statewide Medicaid Managed

746738 Care program established pursuant to part IV of chapter 409 and

747739 the state group insurance program pursuant to part I of chapter

748740 110.

749741 2. The term excludes such a plan or program under

s. 430.84

750

742

or

chapter 440.

751743 (23) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A

752744 PARTICIPATING PHARMACY BENEFITS PLAN OR PROGRAM.—In addition to anyother otherrequirements in the

753745 requirements in the Florida Insurance Code, alla contractualparticipation contract executed,

754746 arrangements executed, amended, adjusted, or renewed on or after July 1, 2023, that

755 July 1, 2023, which are applicable to pharmacy benefits covered

747 applies to pharmacist services on or after January 1, 2024,

756748 on or after January 1, 2024, between a pharmacy benefit manager and one or more pharmacies or

757749 and a pharmacy benefits plan or programpharmacists, must include, in substantial form, terms that

758750 substantial form, terms that ensure compliance with all of the following requirements, and

759751 following requirements and that, except to the extent not allowed by law, shall supersede

760752 allowed by law, shall supersede any contractual terms in the participation contract to the

761753 contrary:

762 (e) Include network adequacy requirements that meet or

763 exceed Medicare Part D program standards for convenient access

764 to the network pharmacies set forth in 42 C.F.R. s.

765 423.120(a)(1) and that:

766 1. Do not limit a network to solely include affiliated

767 pharmacies;

768 2. Require a pharmacy benefit manager to offer a provider

769 contract to licensed pharmacies physically located on the

770 physical site of providers that are:

771 a. Within the pharmacy benefits plan’s or program’s

772 geographic service area and that have been specifically

773 designated as essential providers by the Agency for Health Care

774 Administration pursuant to s. 409.975(1)(a);

775 b. Designated as cancer centers of excellence under s.

776 381.925, regardless of the pharmacy benefits plan’s or program’s

777 geographic service area;

778 c. Organ transplant hospitals, regardless of the pharmacy

779 benefits plan’s or program’s geographic service area;

780 d. Hospitals licensed as specialty children’s hospitals as

781 defined in s. 395.002; or

782 e. Regional perinatal intensive care centers as defined in

783 s. 383.16(2), regardless of the pharmacy benefits plan’s or

784 program’s geographic service area.

785

786 Such provider contracts must be solely for the administration

787

and

or

dispensing of covered prescription drugs

, including

788

biological products, which are administered through infusions,

789

intravenously injected, or inhaled during a surgical procedure

790

or are covered parenteral drugs,

as part of

onsite

outpatient

791 care;

792 3. Do not require a covered person to receive a

793 prescription drug by United States mail, common carrier, local

794 courier, third-party company or delivery service, or pharmacy

795 direct delivery unless the prescription drug cannot be acquired

796 at any retail pharmacy in the pharmacy benefit manager’s network

754 (c) A prohibition of financial clawbacks, reconciliation

797755 foroffsets, theor coveredoffsets person’sto adjudicated claims. A pharmacy benefits plan or program. Thisbenefit

798 subparagraph does not prohibit a pharmacy benefit manager from

799 operating mail order or delivery programs on an opt-in basis at

800 the sole discretion of a covered person, provided that the

801 covered person is not penalized through the imposition of any

802 additional retail cost-sharing obligations or a lower allowed

803 quantity limit for choosing not to select the mail order or

804 delivery programs;

805 4. For the in-person administration of covered prescription

806 drugs, prohibit requiring a covered person to receive pharmacist

807 services from an affiliated pharmacy or an affiliated health

808 care provider; and

809 5. Prohibit offering or implementing pharmacy networks that

810 require or provide a promotional item or an incentive, defined

811 as anything other than a reduced cost-sharing amount or enhanced

812 quantity limit allowed under the benefit design for a covered

813 drug, to a covered person to use an affiliated pharmacy or an

814 affiliated health care provider for the in-person administration

815 of covered prescription drugs; or advertising, marketing, or

816 promoting an affiliated pharmacy to covered persons. Subject to

817 the foregoing, a pharmacy benefit manager may include an

818 affiliated pharmacy in communications to covered persons

819 regarding network pharmacies and prices, provided that the

820 pharmacy benefit manager includes information, such as links to

821 all nonaffiliated network pharmacies, in such communications and

822 that the information provided is accurate and of equal

823 prominence. This subparagraph may not be construed to prohibit a

824 pharmacy benefit manager from entering into an agreement with an

825 affiliated pharmacy to provide pharmacist services to covered

826 persons.

827 (g) Prohibit a pharmacy benefit manager from instituting a

828 network that requires a pharmacy to meet accreditation standards

829 inconsistent with or more stringent than applicable federal and

830 state requirements for licensure and operation as a pharmacy in

831 this state. However, a pharmacy benefit manager may specify

832 additional specialty networks that require enhanced standards

833 related to the safety and competency necessary to meet the

834 United States Food and Drug Administration’s limited

835 distribution requirements for dispensing any drug that, on a

836 drug-by-drug basis, requires extraordinary special handling

,

837

provider coordination, or clinical care or monitoring

when such

838 extraordinary requirements cannot be met by a retail pharmacy.

839 For purposes of this paragraph, drugs requiring extraordinary

840 special handling are limited to drugs that are subject to a risk

841 evaluation and mitigation strategy approved by the United States

842 Food and Drug Administration and that:

843 1. Require special certification of a health care provider

844 to prescribe, receive, dispense, or administer; or

845 2. Require special handling due to the molecular complexity

846 or cytotoxic properties of the biologic or biosimilar product or

847 drug.

848

849 For participation in a specialty network, a pharmacy benefit

850756 manager may not requirecharge, a pharmacy to meet requirements forwithhold,

851 participation beyond those necessary to demonstrate the

852 pharmacy’s ability to dispense the drug in accordance with the

853 United States Food and Drug Administration’s approved

854 manufacturer labeling.

855 (3) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A

856 PARTICIPATING PHARMACY.—In addition to other requirements in the

857 Florida Insurance Code, a participation contract executed,

858 amended, adjusted, or renewed on or after July 1, 2023, that

859 applies to pharmacist services on or after January 1, 2024,

860 between a pharmacy benefit manager and one or more pharmacies or

861 pharmacists, must include, in substantial form, terms that

862 ensure compliance with all of the following requirements, and

863 that, except to the extent not allowed by law, shall supersede

864 any contractual terms in the participation contract to the

865 contrary:

866 (c) A prohibition of financial clawbacks, reconciliation

867 offsets, or offsets to adjudicated claims. A pharmacy benefit

868 manager may not charge, withhold,

offset,

or recoup

any

direct

869757 or indirect remuneration fees, dispensing fees, brand name or

870758 generic effective rate adjustments through reconciliation, or

871759 any other monetary charge, withholding, or recoupments as

872760 related to discounts, multiple network reconciliation offsets,

873761 adjudication transaction fees, and any other instance when

an

874

762

amount

a fee

may be recouped from a pharmacy

if such action

875

763

would result in a reduction in the amount paid to the pharmacy

876764

or pharmacist

. This prohibition does not apply to:

877765 1. Any incentive payments provided by the pharmacy benefit

878766 manager to a network pharmacy for meeting or exceeding

879767 predefined quality measures, such as Healthcare Effectiveness

880768 Data and Information Set measures; recoupment due to an

881769 erroneous claim, fraud, waste, or abuse; a claim adjudicated in

882770 error; a maximum allowable cost appeal pricing adjustment; or an

883771 adjustment made as part of a pharmacy audit pursuant to s.

884772 624.491.

885773 2. Any recoupment that is returned to the state for

886774 programs in chapter 409 or the state group insurance program in

887775 s. 110.123.

888776 (h) The pharmacy benefit manager shall provide a reasonable

889777 administrative appeal procedure to allow a pharmacy or

890778 pharmacist to challenge the maximum allowable cost pricing

891779 information and the reimbursement made under the maximum

892780 allowable cost as defined in s. 627.64741 for a specific drug as

893781 being below the acquisition cost available to the challenging

894782 pharmacy or pharmacist.

895783 1. The administrative appeal procedure must include a

896784 telephone number and e-mail address, or a website, for the

897785 purpose of submitting the administrative appeal. The appeal may

898786 be submitted by the pharmacy or an agent of the pharmacy

899787 directly to the pharmacy benefit manager or through a pharmacy

900788 service administration organization.

The administrative appeal

901

789

process must allow a pharmacy or pharmacist the option to submit

902790

an electronic spreadsheet or similar electronic document

903

791

containing a consolidated administrative appeal representing

904

792

multiple adjudicated claims that share the same drug

and

day

905

793

supply and ha

ve

a date of service occurring within the same

906

794

calendar month.

The pharmacy or pharmacist must be given at

907795 least 30 business days after a maximum allowable cost update or

908796 after an adjudication for an electronic claim or reimbursement

909797 for a nonelectronic claim to file the administrative appeal.

910798 2. The pharmacy benefit manager must respond to the

911799 administrative appeal within 30 business days after receipt of

912800 the appeal.

913801 3. If the appeal is upheld, the pharmacy benefit manager

914802 must:

915803 a. Update the maximum allowable cost pricing information to

916804 at least the acquisition cost available to the pharmacy;

917805 b. Permit the pharmacy or pharmacist to reverse and rebill

918806 the claim in question;

919807 c. Provide to the pharmacy or pharmacist the national drug

920808 code on which the increase or change is based; and

921809 d. Make the increase or change effective for each similarly

922810 situated pharmacy or pharmacist who is subject to the applicable

923811 maximum allowable cost pricing information.

924812 4. If the appeal is denied, the pharmacy benefit manager

925813 must provide to the pharmacy or pharmacist the national drug

926814 code and the name of the national or regional pharmaceutical

927815 wholesalers operating in this state which have the drug

928816 currently in stock at a price below the maximum allowable cost

929817 pricing information.

930818 5.

Beginning August 15, 2026

Every 90 days

, a pharmacy

931819 benefit manager shall report to the office the total number of

932820 appeals received and denied in the preceding

quarter

90-day

933

821

period

, with an explanation or reason for each denial, for each

934822 specific drug for which an appeal was submitted pursuant to this

935823 paragraph.

The deadlines for each filing are March 1 for the

936

824

preceding year

′

s

fourth

quarter; May 15 for each year

the

year

′

s

first

937

825

quarter; August 15 for each year

the

year

′

s

second

quarter; and November

938

826

15 for each year

the

year

′

s

third

quarter.

939827 Section 8. Subsection (7) of section 626.8827, Florida

940828 Statutes, is amended, and subsections (8), (9), and (10) are

941829 added to that section, to read:

942830 626.8827 Pharmacy benefit manager prohibited practices.—In

943831 addition to other prohibitions in this part, a pharmacy benefit

944832 manager may not do any of the following:

945833 (7) Fail to comply with the requirements in s. 624.491 or

946834 s. 626.8825

, or breach contractual terms required under s.

947

835

626.8825

.

948

836

(8) Prohibit or restrict a pharmacy from declining to

949

837

dispense a drug if the reimbursement rate for the drug is less

950

838

than the actual acquisition cost to the pharmacy.

951

839

(

9

) Reimburse a pharmacy less than it reimburses an

952

840

affiliate pharmacy.

953

841

(

10

) Maintain an ownership interest, investment interest,

954

842

or common ownership with an affiliated manufacturer, or share

955

843

any investor or holder of an ownership interest with an

956

844

affiliated manufacturer.

957845 Section 9. Subsection (1) of section 627.42392, Florida

958846 Statutes, is amended to read:

959847 627.42392 Prior authorization.—

960848 (1) As used in this section, the term “health insurer”

961849 means an authorized insurer offering health insurance as defined

962850 in s. 624.603, a managed care plan as defined in

s. 409.962

s.

963

851

409.962(10)

, or a health maintenance organization as defined in

964852 s. 641.19(12).

965853 Section 10. Except as otherwise provided in this act and

966854 except for this section, which shall take effect upon this act

967855 becoming a law, this act shall take effect July 1, 2026.

Volver al texto completo